Ευρωπαϊκή Ένωση - Ιταλικά - EMA (European Medicines Agency)

sandoz gmbh - rivastigmina - dementia; alzheimer disease; parkinson disease - psychoanaleptics, - trattamento sintomatico della demenza di alzheimer da lieve a moderatamente grave. trattamento sintomatico di entità da lieve a moderatamente grave demenza in pazienti con malattia di parkinson idiopatica.

Ευρωπαϊκή Ένωση - Ιταλικά - EMA (European Medicines Agency)

novartis europharm limited - rivastigmina - alzheimer disease; parkinson disease; dementia - psychoanaleptics, - trattamento sintomatico della demenza di alzheimer da lieve a moderatamente grave. trattamento sintomatico di entità da lieve a moderatamente grave demenza in pazienti con malattia di parkinson idiopatica.

Ευρωπαϊκή Ένωση - Ιταλικά - EMA (European Medicines Agency)

actavis group ptc ehf - rivastigmina idrogeno tartrato - dementia; alzheimer disease; parkinson disease - psychoanaleptics, - trattamento sintomatico della demenza di alzheimer da lieve a moderatamente grave. trattamento sintomatico di entità da lieve a moderatamente grave demenza in pazienti con malattia di parkinson idiopatica.

Ιταλία - Ιταλικά - AIFA (Agenzia Italiana del Farmaco)

italfarmaco s.p.a. - rivastigmina - rivastigmina

Ελβετία - Ιταλικά - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - rivastigminum - cerotto transdermico - rivastigminum 9 mg, butylis methacrylatis et methylis methacrylatis polymerisatum, acrylic adhesive, int-rac-alpha-tocopherolum, silicone adhesive, dimeticonum, trägermaterial: poly(ethylenis terephthalas), drucktinte (beige): ad praeparationem pro 5 cm², cum liberatione 4.6 mg/24h. - demenza di tipo alzheimer - synthetika

Ελβετία - Ιταλικά - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - rivastigminum - cerotto transdermico - rivastigminum 18 mg, butylis methacrylatis et methylis methacrylatis polymerisatum, acrylic adhesive, int-rac-alpha-tocopherolum, silicone adhesive, dimeticonum, trägermaterial: poly(ethylenis terephthalas), drucktinte (beige): ad praeparationem pro 10 cm², cum liberatione 9.5 mg/24h. - demenza di tipo alzheimer - synthetika

Ελβετία - Ιταλικά - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - rivastigminum - cerotto transdermico - rivastigminum 27 mg, butylis methacrylatis et methylis methacrylatis polymerisatum, acrylic adhesive, int-rac-alpha-tocopherolum, silicone adhesive, dimeticonum, trägermaterial: poly(ethylenis terephthalas), drucktinte (beige): ad praeparationem pro 15 cm², cum liberatione 13.3 mg/24h. - demenza di tipo alzheimer - synthetika

Ελβετία - Ιταλικά - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - rivastigminum - cerotto transdermico - rivastigminum 9 mg, butylis methacrylatis et methylis methacrylatis polymerisatum, acrylic adhesive, int-rac-alpha-tocopherolum, silicone adhesive, dimeticonum, trägermaterial: poly(ethylenis terephthalas), drucktinte (beige): ad praeparationem pro 5 cm², cum liberatione 4.6 mg/24h. - demenza di tipo alzheimer - synthetika

Ελβετία - Ιταλικά - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - rivastigminum - cerotto transdermico - rivastigminum 18 mg, butylis methacrylatis et methylis methacrylatis polymerisatum, acrylic adhesive, int-rac-alpha-tocopherolum, silicone adhesive, dimeticonum, trägermaterial: poly(ethylenis terephthalas), drucktinte (beige): ad praeparationem pro 10 cm², cum liberatione 9.5 mg/24h. - demenza di tipo alzheimer - synthetika

Ελβετία - Ιταλικά - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - rivastigminum - cerotto transdermico - rivastigminum 27 mg, butylis methacrylatis et methylis methacrylatis polymerisatum, acrylic adhesive, int-rac-alpha-tocopherolum, silicone adhesive, dimeticonum, trägermaterial: poly(ethylenis terephthalas), drucktinte (beige): ad praeparationem pro 15 cm², cum liberatione 13.3 mg/24h. - demenza di tipo alzheimer - synthetika